MiR-495-3p inhibited the proliferation and migration and promoted the apoptosis of CRC cells by downregulating the expression of HMGB1, suggesting that miR-495-3p could be a potential target for the treatment of CRC. The gene discussed is HMGB1; the disease is colorectal carcinoma.